Frontiers | Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
Pathogenic variant detection rate by whole exome sequencing in Thai patients with biopsy-proven focal segmental glomerulosclerosis | Scientific Reports
Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial - ScienceDirect
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis | BMC Nephrology | Full Text
Therapeutic trials in adult FSGS: lessons learned and the road forward | Nature Reviews Nephrology
Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades
PDF] Treatment of primary FSGS in adults. | Semantic Scholar
Frontiers | Collapsing Glomerulopathy: A Review by the Collapsing Brazilian Consortium
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life - ScienceDirect
Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange | Italian Journal of Pediatrics | Full Text
Edgar V. Lerma 🇵🇭 on Twitter: "Secondary FSGS: Treatment #Nephpearls https://t.co/wqujEXfXjK https://t.co/eXHalPNobb" / Twitter
Clinical manifestations of focal segmental glomerulosclerosis in Japan from the Japan Renal Biopsy Registry: age stratification and comparison with minimal change disease | Scientific Reports
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin - ScienceDirect
Focal Segmental Glomerulosclerosis | NEJM
Presumed” Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid Therapy - Kidney International Reports